UW Health, medical school switch kidney test to improve healthcare equity

UW Health and University of Wisconsin School of Medicine and Public Health in Madison are eliminating race from a routinely used formula that estimates kidney function in a move to improve equity in healthcare, officials announced Oct. 1.

Advertisement

Arjang Djamali, MD, professor at the UW School of Medicine and Public Health, and UW Health nephrologist, said that a formerly used formula to estimate kidney function could overestimate the kidney function of Black patients and lead to care delays for Black patients. 

UW Health now uses a confirmatory biological blood test, known as cystatin C-based GFR test, that does not include race. 

UW Health, a seven-hospital system, began using the alternative test Oct 1. 

 

More articles on strategy:
United Airlines launches COVID-19 testing program for travelers
Geisinger’s food service strategy amid the pandemic: Insights from senior director Steve Cerullo
Viewpoint: Plan on an unusual 2021, too

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Strategy

Advertisement

Comments are closed.